Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Blockbuster-Bohrergebnisse: Gold-Antimon-Fund in Nevada trifft geopolitischen Nerv
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A413TB | ISIN: KYG93Y5D1039 | Ticker-Symbol: T06
Frankfurt
27.06.25 | 08:02
5,000 Euro
-1,96 % -0,100
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
VISEN PHARMACEUTICALS Chart 1 Jahr
5-Tage-Chart
VISEN PHARMACEUTICALS 5-Tage-Chart

Aktuelle News zur VISEN PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.06.VISEN PHARMA-B (02561): SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING2
12.06.VISEN PHARMA-B (02561): SECOND FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 27 JUNE 2025 AT 3:00 P.M.1
12.06.VISEN PHARMA-B (02561): (1) CONTINUING CONNECTED TRANSACTION IN RELATION TO THE COMMERCIAL SUPPLY FRAMEWORK AGREEMENT; (2) PROPOSED GRANT OF AWARD SHARES; ...-
VISEN PHARMACEUTICALS Aktie jetzt für 0€ handeln
12.06.VISEN PHARMA-B (02561): GRANT OF AWARD SHARES3
12.06.VISEN PHARMA-B (02561): CONTINUING CONNECTED TRANSACTION COMMERCIAL SUPPLY FRAMEWORK AGREEMENT-
30.04.VISEN PHARMA-B (02561): NOTICE OF ANNUAL GENERAL MEETING-
30.04.VISEN PHARMA-B (02561): FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 27 JUNE 2025 AT 3:00 P.M.-
30.04.VISEN PHARMA-B (02561): (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES ...-
30.04.VISEN PHARMA-B (02561): 2024 ANNUAL REPORT-
25.04.VISEN PHARMA-B (02561): NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM1
25.04.VISEN PHARMA-B (02561): NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM1
17.04.VISEN PHARMA-B (02561): STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF THE OVER-ALLOTMENT OPTION3
27.03.VISEN PHARMA-B (02561): FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024-
24.03.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 24.03.2025494The following instruments on XETRA do have their first trading 24.03.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.03.2025 Aktien 1 KYG93Y5D1039 VISEN Pharmaceuticals 2...
► Artikel lesen
20.03.VISEN PHARMA-B (02561): ANNOUNCEMENT OF ALLOTMENT RESULTS2
20.03.VISEN PHARMA-B (02561): CLARIFICATION ANNOUNCEMENT IN RELATION TO PRINCIPAL PLACE OF BUSINESS IN HONG KONG1
19.03.VISEN PHARMA-B (02561): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS2
19.03.VISEN PHARMA-B (02561): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE5
19.03.VISEN PHARMA-B (02561): TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE1
19.03.VISEN PHARMA-B (02561): TERMS OF REFERENCE OF THE AUDIT COMMITTEE3
Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1